Search Page

1

Cite

Share

Nanobodies as novel therapeutic agents in envenomation.

Alirahimi E, Kazemi-Lomedasht F, Shahbazzadeh D, Habibi-Anbouhi M, Hosseininejad Chafi M, Sotoudeh N, Ghaderi H, Muyldermans S, Behdani M. Alirahimi E, et al. Among authors: behdani m. Biochim Biophys Acta Gen Subj. 2018 Dec;1862(12):2955-2965. doi: 10.1016/j.bbagen.2018.08.019. Epub 2018 Aug 30. Biochim Biophys Acta Gen Subj. 2018. PMID: 30309831 Review.

Cite

Share

2

Cite

Share

Designing and Development of a Tandem Bivalent Nanobody against VEGF₁₆₅.

Khodabakhsh F, Salimian M, Ziaee P, Kazemi-Lomedasht F, Behdani M, Ahangari Cohan R. Khodabakhsh F, et al. Among authors: behdani m. Avicenna J Med Biotechnol. 2021 Apr-Jun;13(2):58-64. doi: 10.18502/ajmb.v13i2.5519. Avicenna J Med Biotechnol. 2021. PMID: 34012520 Free PMC article.

Cite

Share

3

Cite

Share

Expressing of Recombinant VEGFR2-specific Nanobody in Baculovirus Expression System.

Shokrollahi N, Habibi-Anbouhi M, Jahanian-Najafabadi A, Alirahimi E, Behdani M. Shokrollahi N, et al. Among authors: behdani m. Iran J Biotechnol. 2021 Jan 1;19(1):e2783. doi: 10.30498/IJB.2021.2783. eCollection 2021 Jan. Iran J Biotechnol. 2021. PMID: 34179196 Free PMC article.

Cite

Share

4

Cite

Share

Liposomal delivery of vascular endothelial growth factor/receptors and their inhibitors.

Khodabakhsh F, Muyldermans S, Behdani M, Kazemi-Lomedasht F. Khodabakhsh F, et al. Among authors: behdani m. J Drug Target. 2020 Apr;28(4):379-385. doi: 10.1080/1061186X.2019.1693578. Epub 2019 Dec 10. J Drug Target. 2020. PMID: 31822133 Review.

Cite

Share

5

Cite

Share

Single-Domain Antibodies or Nanobodies: A Class of Next-Generation Antibodies.

Khodabakhsh F, Behdani M, Rami A, Kazemi-Lomedasht F. Khodabakhsh F, et al. Among authors: behdani m. Int Rev Immunol. 2018;37(6):316-322. doi: 10.1080/08830185.2018.1526932. Epub 2019 Feb 11. Int Rev Immunol. 2018. PMID: 30741045 Review.

Cite

Share

6

Cite

Share

Development of camelid monoclonal nanobody against SLC39A6 zinc transporter protein.

Ghaderi H, Noormohammadi Z, Habibi-Anbouhi M, Kazemi-Lomedasht F, Behdani M. Ghaderi H, et al. Among authors: behdani m. Iran J Basic Med Sci. 2021 Dec;24(12):1726-1733. doi: 10.22038/IJBMS.2021.58542.13003. Iran J Basic Med Sci. 2021. PMID: 35432806 Free PMC article.

Cite

Share

7

Cite

Share

Nanobodies as powerful pulmonary targeted biotherapeutics against SARS-CoV-2, pharmaceutical point of view.

Najmeddin A, Bahrololoumi Shapourabadi M, Behdani M, Dorkoosh F. Najmeddin A, et al. Among authors: behdani m. Biochim Biophys Acta Gen Subj. 2021 Nov;1865(11):129974. doi: 10.1016/j.bbagen.2021.129974. Epub 2021 Jul 31. Biochim Biophys Acta Gen Subj. 2021. PMID: 34343644 Free PMC article. Review.

Cite

Share

8

Cite

Share

A nanobody-derived mimotope against VEGF inhibits cancer angiogenesis.

Karami E, Sabatier JM, Behdani M, Irani S, Kazemi-Lomedasht F. Karami E, et al. Among authors: behdani m. J Enzyme Inhib Med Chem. 2020 Dec;35(1):1233-1239. doi: 10.1080/14756366.2020.1758690. J Enzyme Inhib Med Chem. 2020. PMID: 32441172 Free PMC article.

Cite

Share

9

Cite

Share

In Vivo Tumor Therapy with Novel Immunotoxin Containing Programmed Cell Death Protein-1 and Diphtheria Toxin.

Mousavi A, Sabouri A, Hassanzadeh Eskafi A, Alirahimi E, Kazemi-Lomedasht F, Ghaderi H, Behdani M. Mousavi A, et al. Among authors: behdani m. Monoclon Antib Immunodiagn Immunother. 2021 Jun;40(3):113-117. doi: 10.1089/mab.2020.0043. Epub 2021 Jun 1. Monoclon Antib Immunodiagn Immunother. 2021. PMID: 34076502

Cite

Share

10

Cite

Share

Selection and characterization of specific nanobody against neuropilin-1 for inhibition of angiogenesis.

Naderi S, Roshan R, Ghaderi H, Behdani M, Mahmoudi S, Habibi-Anbouhi M, Shokrgozar MA, Kazemi-Lomedasht F. Naderi S, et al. Among authors: behdani m. Mol Immunol. 2020 Dec;128:56-63. doi: 10.1016/j.molimm.2020.10.004. Epub 2020 Oct 15. Mol Immunol. 2020. PMID: 33070092

Cite

Share